Cargando…

Severity and management of psoriasis within primary care

BACKGROUND: Scottish Intercollegiate Guidelines Network and National Institute of Health and Care Excellence guidelines stress the importance of assessing patients with psoriasis for psoriatic arthritis, comorbidities associated with severe disease and quality of life (QoL). The purpose of the study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wade, Alan G., Crawford, Gordon M., Young, David, Leman, Joyce, Pumford, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064962/ https://www.ncbi.nlm.nih.gov/pubmed/27737638 http://dx.doi.org/10.1186/s12875-016-0544-6

Ejemplares similares

Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009–2010 season: web-based and telephone evaluation
por: Wade, Alan G, et al.
Publicado: (2011)

Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation
por: Wade, Alan G, et al.
Publicado: (2011)

Treatment of severe psoriasis with infliximab
por: Leman, JA, et al.
Publicado: (2008)

Severe Mental Illness Among Adults with Atopic Eczema or Psoriasis: Population-Based Matched Cohort Studies within UK Primary Care
por: Adesanya, Elizabeth I, et al.
Publicado: (2023)

A survey of patient preferences for a placebo orodispersible tablet
por: Wade, Alan G, et al.
Publicado: (2012)

Biologics in the management of psoriasis
por: Bahner, Jennifer D, et al.
Publicado: (2009)

Circadian rhythms in psoriasis and the potential of chronotherapy in psoriasis management
por: Luengas‐Martinez, Andrea, et al.
Publicado: (2022)

Management of a Chronic Skin Disease in Primary Care: An Analysis of Early-Career General Practitioners’ Consultations Involving Psoriasis
por: Nawaz, Sameerah, et al.
Publicado: (2021)

Management of Moderate to Severe Psoriasis in Patients with Metabolic Comorbidities
por: Gisondi, Paolo, et al.
Publicado: (2015)

THE MANAGEMENT OF MODERATE TO SEVERE PSORIASIS: A BIOLOGIC REVOLUTION
por: Skillen, LA, et al.
Publicado: (2018)

Primary care‐based screening for cardiovascular risk factors in patients with psoriasis
por: Rutter, M.K., et al.
Publicado: (2016)

Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
por: Kimball, Alexa B., et al.
Publicado: (2021)

Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
por: Wu, J.J., et al.
Publicado: (2022)

Comparison of diclofenac gel, ibuprofen gel, and ibuprofen gel with levomenthol for the topical treatment of pain associated with musculoskeletal injuries
por: Wade, Alan G., et al.
Publicado: (2019)

Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents
por: MELIN, Audrey, et al.
Publicado: (2021)

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
por: Jin, Joy Q, et al.
Publicado: (2023)

Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line
por: Strober, Bruce, et al.
Publicado: (2021)

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1
por: Strober, Bruce E., et al.
Publicado: (2012)

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2
por: Strober, Bruce E., et al.
Publicado: (2012)

Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
por: Wade, Alan G, et al.
Publicado: (2011)

The experience of pain and redness in patients with moderate to severe plaque psoriasis
por: Martin, Mona L., et al.
Publicado: (2015)

Immunotargeting in the management of psoriasis
por: Kaffenberger, Benjamin H, et al.
Publicado: (2013)

A New Classification of the Severity of Psoriasis: What’s Moderate Psoriasis?
por: Salgado-Boquete, Laura, et al.
Publicado: (2021)

Treatment challenges in the management of moderate-to-severe plaque psoriasis – role of secukinumab
por: Malakouti, Mona, et al.
Publicado: (2016)

Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece
por: Avgerinou, Georgia, et al.
Publicado: (2012)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
por: Ruggiero, Angelo, et al.
Publicado: (2023)

Therapy of moderate and severe psoriasis
por: Claes, Christa, et al.
Publicado: (2006)

Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis
por: Feng, Bing-Jian, et al.
Publicado: (2009)

Management of psoriasis in adolescence
por: Fotiadou, Christina, et al.
Publicado: (2014)

Management der Psoriasis
por: Mrowietz, Ulrich
Publicado: (2021)

Psoriasis Prevalence and Severity by Expert Elicitation
por: Papp, Kim A., et al.
Publicado: (2021)

The Budget Impact of Introducing Tildrakizumab to a United States Health Plan for Managing Moderate-to-Severe Plaque Psoriasis
por: Carrico, Justin, et al.
Publicado: (2020)

Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis
por: Alcusky, Matthew, et al.
Publicado: (2017)

Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis
por: Strohal, R, et al.
Publicado: (2014)

Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis
por: Suárez-Fariñas, Mayte, et al.
Publicado: (2012)

Nontuberculous mycobacterial disease managed within UK primary care, 2006–2016
por: Axson, Eleanor L., et al.
Publicado: (2018)

Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis
por: Verbenko, Dmitry A., et al.
Publicado: (2020)

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
por: Wade, Alan G, et al.
Publicado: (2010)

Severe Scalp Psoriasis Microbiome Has Increased Biodiversity and Relative Abundance of Pseudomonas Compared to Mild Scalp Psoriasis
por: Choi, Jin-Young, et al.
Publicado: (2022)

Real-world Efficacy and Safety of Apremilast Monotherapy in the Management of Moderate-to-severe Psoriasis
por: Shah, Bela J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s4ehqug4adk01oh73vvtmjr5m6